Patient Assistance Programs
Medication is costly. Even the pills, solutions and syrups that are used on a day-to-day basis can become a large part of the budget. Therefore, it is not surprising how much costlier specialty medicines might be. A lot of research goes into understanding and studying various symptoms and conditions of diseases. Further, research to cure or prevent them is time-consuming and expensive. On top of that, add the capitalism of Big Pharma companies to this cocktail. As a result, common masses for whom such medicines become a necessity, have to bear the brunt of high prices. Many patients and their families can barely afford a lot of rare medications. Those, who are able to cannot continue for long or incur large debts. This is where the Patient Assistance Programs come to the rescue. Pharmaceutical Manufacturers often sponsor P atient Assistance Programs (or PAPs) for individuals who cannot afford their medication. The importance of PAPs is multi-fold. Even with self-bought ...